Series

Pinnacle Medicines, a pioneer in oral peptide therapeutics, announced an additional $89 million in Series B funding to advance its pipeline into clinical trials.

by
Pinnacle Medicines, a pioneer in oral peptide therapeutics, announced an additional $89 million in Series B funding to advance its pipeline into clinical trials.

The financing was co-led by LAV and Foresite Capital with participation from existing investors including Quan Capital, Hankang Capital, RA Capital Management, Logos Capital and OrbiMed. The company has raised $134 million to date after incubation by OrbiMed and other healthcare specialist investors. Achievements will support the advancement of the oral peptide pipeline through clinical … Read more

Article Care Announces $45 Million Series A to Scale AI-Powered Clinical Teams Across Healthcare

by
Article Care Announces $45 Million Series A to Scale AI-Powered Clinical Teams Across Healthcare

NEW YORK–( BUSINESS WIRE )–Thesis Care (formerly Trovo Health), an AI-powered care team platform for scalable clinical capabilities, announced $45 million in Series A funding with additional backing from Oak HC/FT led by CRV, and Black Opal Ventures and veteran C-level healthcare technology angel investors. This brings the total funding for the article to $60 … Read more